Cancer Nanotechnology

SJR Rank #6,318H-index: 46SJR: 0.849Best quartile: Q1Open AccessAPC: US$1,990Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

BioMed Central Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Pharmaceutical ScienceQ1
  • Physical and Theoretical ChemistryQ1
  • Biomedical EngineeringQ2
  • OncologyQ2

Areas: Chemistry · Engineering · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsRNA Interference and Gene DeliveryGraphene and Nanomaterials ApplicationsAdvanced biosensing and bioanalysis techniquesRadiation Therapy and DosimetryExtracellular vesicles in diseaseAdvanced Nanomaterials in CatalysisNanoparticles: synthesis and applicationsCancer Research and Treatments

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs050100150200

Documents per Year

20222025015304560

Detailed Information

ISSN

1868-6958, 1868-6966

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

6.25

References per Document

94.02

Coverage

2010-2026

Scope

Cancer is a group of diseases driven by inherently nanostructural problems (e.g. DNA issues). As such, there are obvious benefits to treatments employing nanoscale structures and processes. Additionally, as nanotechnologies are developing at a rapid rate, it is likely that many new themes will develop within the area in the next few years. With this in mind, Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.

Metrics from SCImago Journal Rank 2025. View on SCImago